Pill Identifier App

Macimorelin acetate Approval Status

Macimorelin acetate is a ghrelin agonist in development for use in evaluating adult growth hormone deficiency (AGHD).

FDA Approval Status for macimorelin acetate

DateArticle
Jan  6, 2014Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA
Nov  5, 2013Aeterna Zentaris Submits New Drug Application to FDA for Macimorelin Acetate (AEZS-130) for Evaluation of AGHD

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web3)